You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – OpGen announced Tuesday it has issued a formal response to the US Food and Drug Administration's request for additional information for its Acuitas AMR Gene Panel premarket submission.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.